2bst › Citations

Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705.

Stewart-Jones GB, di Gleria K, Kollnberger S, McMichael AJ, Jones EY, Bowness P
Eur J Immunol 35 341-51 (2005)
Related entries: 2bsr, 2bss

Cited: 79 times
EuropePMC logo PMID: 15657948

Abstract

We have solved the crystal structures of three HLA-B*2705-peptide complexes with the immunodominant viral peptides: EBV EBNA3C 258-266 (RRIYDLIEL), influenza (flu) nucleoprotein NP383-391 (SRYWAIRTR), and HIV gag 264-273 (KRWIILGLNK). Long-term non-progression during HIV infection has been associated with presentation by HLA-B*2705, and T cell recognition, of the highly immunodominant KRWIILGLNK peptide. The tight hydrogen-bonding network observed between the HLA-B*2705 B-pocket and the peptide P2 arginine guanadinium anchor explains why mutation of this residue during HIV infection results in loss of peptide binding, immune escape and progression to AIDS. Prominent, solvent-exposed structures within these peptides may participate in generating T cell responses to these immunodominant epitopes. In the HLA-B*2705 complex with flu NP383-391, the amino acid side chains of residues 4, 7 and 8 are solvent-exposed whilst in the HIV decamer, the main-chain bulges into the solvent around P7. Thus, HLA-B*2705 presents viral peptides in a range of conformations. Tetrameric complexes of HLA-B*2705 with the HIV and flu but not EBV peptides bound strongly to the killer-Ig-like receptor (KIR)3DL1. Substitution of EBV P8 glutamate to threonine allowed recognition by KIR3DL1. In the HLA-B*2705-EBV structure the P8 glutamate side chain is solvent-exposed and may inhibit KIR3DL1 binding through electrostatic forces.

Articles - 2bst mentioned but not cited (9)

  1. Prediction and identification of T cell epitopes in the H5N1 influenza virus nucleoprotein in chicken. Hou Y, Guo Y, Wu C, Shen N, Jiang Y, Wang J. PLoS One 7 e39344 (2012)
  2. Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins. Mirza MU, Rafique S, Ali A, Munir M, Ikram N, Manan A, Salo-Ahen OM, Idrees M. Sci Rep 6 37313 (2016)
  3. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Yang X, Garner LI, Zvyagin IV, Paley MA, Komech EA, Jude KM, Zhao X, Fernandes RA, Hassman LM, Paley GL, Savvides CS, Brackenridge S, Quastel MN, Chudakov DM, Bowness P, Yokoyama WM, McMichael AJ, Gillespie GM, Garcia KC. Nature 612 771-777 (2022)
  4. Interaction pattern of Arg 62 in the A-pocket of differentially disease-associated HLA-B27 subtypes suggests distinct TCR binding modes. Nurzia E, Narzi D, Cauli A, Mathieu A, Tedeschi V, Caristi S, Sorrentino R, Böckmann RA, Fiorillo MT. PLoS ONE 7 e32865 (2012)
  5. Characterization of a proteasome and TAP-independent presentation of intracellular epitopes by HLA-B27 molecules. Magnacca A, Persiconi I, Nurzia E, Caristi S, Meloni F, Barnaba V, Paladini F, Raimondo D, Fiorillo MT, Sorrentino R. J. Biol. Chem. 287 30358-30367 (2012)
  6. Loss of recognition by cross-reactive T cells and its relation to a C-terminus-induced conformational reorientation of an HLA-B*2705-bound peptide. Loll B, Rückert C, Hee CS, Saenger W, Uchanska-Ziegler B, Ziegler A. Protein Sci. 20 278-290 (2011)
  7. Salt bridge-forming residues positioned over viral peptides presented by MHC class I impacts T-cell recognition in a binding-dependent manner. Ji W, Niu L, Peng W, Zhang Y, Cheng H, Gao F, Shi Y, Qi J, Gao GF, Liu WJ. Mol Immunol 112 274-282 (2019)
  8. Phosphosite-dependent presentation of dual phosphorylated peptides by MHC class I molecules. Zhao Y, Sun M, Zhang N, Liu X, Yue C, Feng L, Ji S, Liu X, Qi J, Wong CCL, Gao GF, Liu WJ. iScience 25 104013 (2022)
  9. Unveiling the functional epitopes of cobra venom cytotoxin by immunoinformatics and epitope-omic analyses. Hiu JJ, Fung JKY, Tan HS, Yap MKK. Sci Rep 13 12271 (2023)


Reviews citing this publication (16)

  1. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Bashirova AA, Martin MP, McVicar DW, Carrington M. Annu Rev Genomics Hum Genet 7 277-300 (2006)
  2. NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. Alter G, Altfeld M. J. Intern. Med. 265 29-42 (2009)
  3. HLA-B27. Bowness P. Annu. Rev. Immunol. 33 29-48 (2015)
  4. Structural and dynamic control of T-cell receptor specificity, cross-reactivity, and binding mechanism. Baker BM, Scott DR, Blevins SJ, Hawse WF. Immunol. Rev. 250 10-31 (2012)
  5. A bird's eye view of NK cell receptor interactions with their MHC class I ligands. Saunders PM, Vivian JP, O'Connor GM, Sullivan LC, Pymm P, Rossjohn J, Brooks AG. Immunol. Rev. 267 148-166 (2015)
  6. HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications. Busch R, Kollnberger S, Mellins ED. Nat Rev Rheumatol 15 364-381 (2019)
  7. The Role of Natural Killer Cells in Autoimmune Diseases. Kucuksezer UC, Aktas Cetin E, Esen F, Tahrali I, Akdeniz N, Gelmez MY, Deniz G. Front Immunol 12 622306 (2021)
  8. Hepatitis C virus spontaneous clearance: immunology and genetic variance. Amini M, Poustchi H. Viral Immunol. 25 241-248 (2012)
  9. The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function. O'Connor GM, McVicar D. Crit. Rev. Immunol. 33 203-218 (2013)
  10. NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome. Pyzik M, Kielczewska A, Vidal SM. Semin. Immunol. 20 331-342 (2008)
  11. Killer immunoglobulin-like receptor genes in uveitis. Levinson RD. Ocul. Immunol. Inflamm. 19 192-201 (2011)
  12. Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections? Crux NB, Elahi S. Front Immunol 8 832 (2017)
  13. Mouse models of efficient and inefficient anti-tumor immunity, with emphasis on minimal residual disease and tumor escape. Egorov IK. Cancer Immunol. Immunother. 55 1-22 (2006)
  14. Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection. Hölzemer A, Garcia-Beltran WF, Altfeld M. Front Immunol 8 1496 (2017)
  15. KIRigami: the case for studying NK cell receptors in SIV+ macaques. Bimber B, O'Connor DH. Immunol. Res. 40 235-243 (2008)
  16. Key role of human leukocyte antigen in modulating human immunodeficiency virus progression: An overview of the possible applications. Grifoni A, Montesano C, Colizzi V, Amicosante M. World J Virol 4 124-133 (2015)

Articles citing this publication (54)

  1. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, Bornstein E, Asher TE, Samri A, Schnuriger A, Theodorou I, Costagliola D, Rouzioux C, Agut H, Marcelin AG, Douek D, Autran B, Appay V. J. Exp. Med. 204 2473-2485 (2007)
  2. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, Schneidewind A, Streeck H, Waring M, Meier A, Brander C, Lifson JD, Allen TM, Carrington M, Altfeld M. J. Exp. Med. 204 3027-3036 (2007)
  3. HIV-1 adaptation to NK-cell-mediated immune pressure. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, Oniangue-Ndza C, Martin M, Li B, Khakoo SI, Carrington M, Allen TM, Altfeld M. Nature 476 96-100 (2011)
  4. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Chen H, Ndhlovu ZM, Liu D, Porter LC, Fang JW, Darko S, Brockman MA, Miura T, Brumme ZL, Schneidewind A, Piechocka-Trocha A, Cesa KT, Sela J, Cung TD, Toth I, Pereyra F, Yu XG, Douek DC, Kaufmann DE, Allen TM, Walker BD. Nat. Immunol. 13 691-700 (2012)
  5. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Neumann-Haefelin C, McKiernan S, Ward S, Viazov S, Spangenberg HC, Killinger T, Baumert TF, Nazarova N, Sheridan I, Pybus O, von Weizsäcker F, Roggendorf M, Kelleher D, Klenerman P, Blum HE, Thimme R. Hepatology 43 563-572 (2006)
  6. Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. Dazert E, Neumann-Haefelin C, Bressanelli S, Fitzmaurice K, Kort J, Timm J, McKiernan S, Kelleher D, Gruener N, Tavis JE, Rosen HR, Shaw J, Bowness P, Blum HE, Klenerman P, Bartenschlager R, Thimme R. J. Clin. Invest. 119 376-386 (2009)
  7. A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. Lichterfeld M, Kavanagh DG, Williams KL, Moza B, Mui SK, Miura T, Sivamurthy R, Allgaier R, Pereyra F, Trocha A, Feeney M, Gandhi RT, Rosenberg ES, Altfeld M, Allen TM, Allen R, Walker BD, Sundberg EJ, Yu XG. J. Exp. Med. 204 2813-2824 (2007)
  8. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. Boulet S, Song R, Kamya P, Bruneau J, Shoukry NH, Tsoukas CM, Bernard NF. J Immunol 184 2057-2064 (2010)
  9. Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1. Carlson JM, Brumme CJ, Martin E, Listgarten J, Brockman MA, Le AQ, Chui CK, Cotton LA, Knapp DJ, Riddler SA, Haubrich R, Nelson G, Pfeifer N, Deziel CE, Heckerman D, Apps R, Carrington M, Mallal S, Harrigan PR, John M, Brumme ZL, International HIV Adaptation Collaborative. J. Virol. 86 13202-13216 (2012)
  10. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide. Kollnberger S, Chan A, Sun MY, Chen LY, Wright C, di Gleria K, McMichael A, Bowness P. Eur. J. Immunol. 37 1313-1322 (2007)
  11. Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. Gillespie GM, Bashirova A, Dong T, McVicar DW, Rowland-Jones SL, Carrington M. AIDS Res. Hum. Retroviruses 23 451-455 (2007)
  12. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1. Sanjanwala B, Draghi M, Norman PJ, Guethlein LA, Parham P. J. Immunol. 181 6293-6300 (2008)
  13. An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1. Brackenridge S, Evans EJ, Toebes M, Goonetilleke N, Liu MK, di Gleria K, Schumacher TN, Davis SJ, McMichael AJ, Gillespie GM. J. Virol. 85 5415-5422 (2011)
  14. Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya. Alimonti JB, Kimani J, Matu L, Wachihi C, Kaul R, Plummer FA, Fowke KR. Immunol. Cell Biol. 84 482-485 (2006)
  15. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope. Neumann-Haefelin C, Timm J, Schmidt J, Kersting N, Fitzmaurice K, Oniangue-Ndza C, Kemper MN, Humphreys I, McKiernan S, Kelleher D, Lohmann V, Bowness P, Huzly D, Rosen HR, Kim AY, Lauer GM, Allen TM, Barnes E, Roggendorf M, Blum HE, Thimme R. Hepatology 51 54-62 (2010)
  16. Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1. O'Connor GM, Vivian JP, Gostick E, Pymm P, Lafont BA, Price DA, Rossjohn J, Brooks AG, McVicar DW. J. Virol. 89 5213-5221 (2015)
  17. KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis. Wong-Baeza I, Ridley A, Shaw J, Hatano H, Rysnik O, McHugh K, Piper C, Brackenbridge S, Fernandes R, Chan A, Bowness P, Kollnberger S. J. Immunol. 190 3216-3224 (2013)
  18. Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations. Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC, Bruges Armas J, Suarez-Alvarez B, Pruneda L, Couto AR, Gonzalez S, Lopez-Vázquez A, Martinez-Borra J. Arthritis Res. Ther. 8 R101 (2006)
  19. Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa. Hölzemer A, Thobakgale CF, Jimenez Cruz CA, Garcia-Beltran WF, Carlson JM, van Teijlingen NH, Mann JK, Jaggernath M, Kang SG, Körner C, Chung AW, Schafer JL, Evans DT, Alter G, Walker BD, Goulder PJ, Carrington M, Hartmann P, Pertel T, Zhou R, Ndung'u T, Altfeld M. PLoS Med. 12 e1001900; discussion e1001900 (2015)
  20. Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity. O'Connor GM, Vivian JP, Widjaja JM, Bridgeman JS, Gostick E, Lafont BA, Anderson SK, Price DA, Brooks AG, Rossjohn J, McVicar DW. J. Immunol. 192 2875-2884 (2014)
  21. Activating KIR genes are associated with ankylosing spondylitis in Asian populations. Díaz-Peña R, Blanco-Gelaz MA, Suárez-Alvarez B, Martínez-Borra J, López-Vázquez A, Alonso-Arias R, Brüges-Armas J, Vidal-Castiñeira JR, López-Larrea C. Hum. Immunol. 69 437-442 (2008)
  22. The role of HLA-B27 in spondyloarthritis. Taurog JD. J. Rheumatol. 37 2606-2616 (2010)
  23. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals. Levinson RD, Du Z, Luo L, Monnet D, Tabary T, Brezin AP, Zhao L, Gjertson DW, Holland GN, Reed EF, Cohen JH, Rajalingam R. Genes Immun. 9 249-258 (2008)
  24. Conformation of peptides bound to the transporter associated with antigen processing (TAP). Herget M, Baldauf C, Schölz C, Parcej D, Wiesmüller KH, Tampé R, Abele R, Bordignon E. Proc. Natl. Acad. Sci. U.S.A. 108 1349-1354 (2011)
  25. Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function. van Teijlingen NH, Hölzemer A, Körner C, García-Beltrán WF, Schafer JL, Fadda L, Suscovich TJ, Brander C, Carrington M, Evans DT, van Baarle D, Altfeld M. AIDS 28 1399-1408 (2014)
  26. HLA-B27 heavy chains distinguished by a micropolymorphism exhibit differential flexibility. Fabian H, Huser H, Loll B, Ziegler A, Naumann D, Uchanska-Ziegler B. Arthritis Rheum. 62 978-987 (2010)
  27. MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape. Pymm P, Illing PT, Ramarathinam SH, O'Connor GM, Hughes VA, Hitchen C, Price DA, Ho BK, McVicar DW, Brooks AG, Purcell AW, Rossjohn J, Vivian JP. Nat. Struct. Mol. Biol. 24 387-394 (2017)
  28. Human beta-2 microglobulin W60V mutant structure: Implications for stability and amyloid aggregation. Ricagno S, Raimondi S, Giorgetti S, Bellotti V, Bolognesi M. Biochem. Biophys. Res. Commun. 380 543-547 (2009)
  29. Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy. De Re V, Caggiari L, De Zorzi M, Talamini R, Racanelli V, D' Andrea M, Buonadonna A, Zagonel V, Cecchin E, Innocenti F, Toffoli G. PLoS ONE 9 e84940 (2014)
  30. Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK-cell repertoire in the French population. Gagne K, Willem C, Legrand N, Djaoud Z, David G, Rettman P, Bressollette-Bodin C, Senitzer D, Esbelin J, Cesbron-Gautier A, Schneider T, Retière C. Eur. J. Immunol. 43 1085-1098 (2013)
  31. Degenerate recognition of MHC class I molecules with Bw4 and Bw6 motifs by a killer cell Ig-like receptor 3DL expressed by macaque NK cells. Maloveste SM, Chen D, Gostick E, Vivian JP, Plishka RJ, Iyengar R, Kruthers RL, Buckler-White A, Brooks AG, Rossjohn J, Price DA, Lafont BA. J. Immunol. 189 4338-4348 (2012)
  32. Influence of inflammation-related changes on conformational characteristics of HLA-B27 subtypes as detected by IR spectroscopy. Fabian H, Loll B, Huser H, Naumann D, Uchanska-Ziegler B, Ziegler A. FEBS J. 278 1713-1727 (2011)
  33. Predicting important residues and interaction pathways in proteins using Gaussian Network Model: binding and stability of HLA proteins. Haliloglu T, Gul A, Erman B. PLoS Comput. Biol. 6 e1000845 (2010)
  34. The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope. Saunders PM, Vivian JP, Baschuk N, Beddoe T, Widjaja J, O'Connor GM, Hitchen C, Pymm P, Andrews DM, Gras S, McVicar DW, Rossjohn J, Brooks AG. J. Immunol. 194 781-789 (2015)
  35. The molecular basis of how buried human leukocyte antigen polymorphism modulates natural killer cell function. Saunders PM, MacLachlan BJ, Pymm P, Illing PT, Deng Y, Wong SC, Oates CVL, Purcell AW, Rossjohn J, Vivian JP, Brooks AG. Proc Natl Acad Sci U S A 117 11636-11647 (2020)
  36. Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy. Levinson RD, Martin TM, Luo L, Ashouri E, Rosenbaum JT, Smith JR, Austin CR, Lutt JR, Rajalingam R. Invest. Ophthalmol. Vis. Sci. 51 1505-1510 (2010)
  37. Triple bypass: complicated paths to HIV escape. McMichael AJ. J. Exp. Med. 204 2785-2788 (2007)
  38. The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide. Walpole NG, Kjer-Nielsen L, Kostenko L, McCluskey J, Brooks AG, Rossjohn J, Clements CS. J. Mol. Biol. 397 467-480 (2010)
  39. HLA-B27: portraying immunodominant viral epitopes. López de Castro JA. Eur. J. Immunol. 35 336-340 (2005)
  40. The complex and specific pMHC interactions with diverse HIV-1 TCR clonotypes reveal a structural basis for alterations in CTL function. Xia Z, Chen H, Kang SG, Huynh T, Fang JW, Lamothe PA, Walker BD, Zhou R. Sci Rep 4 4087 (2014)
  41. The domain landscape of virus-host interactomes. Zheng LL, Li C, Ping J, Zhou Y, Li Y, Hao P. Biomed Res Int 2014 867235 (2014)
  42. Allelic association with ankylosing spondylitis fails to correlate with human leukocyte antigen B27 homodimer formation. Lim Kam Sian TCC, Indumathy S, Halim H, Greule A, Cryle MJ, Bowness P, Rossjohn J, Gras S, Purcell AW, Schittenhelm RB. J Biol Chem 294 20185-20195 (2019)
  43. HLA-B*27:05-specific cytotoxic T lymphocyte epitopes in Indian HIV type 1C. Sundaramurthi JC, Ramanathan VD, Hanna LE. AIDS Res. Hum. Retroviruses 29 47-53 (2013)
  44. High-Resolution Characterization of KIR Genes in a Large North American Cohort Reveals Novel Details of Structural and Sequence Diversity. Amorim LM, Augusto DG, Nemat-Gorgani N, Montero-Martin G, Marin WM, Shams H, Dandekar R, Caillier S, Parham P, Fernández-Viña MA, Oksenberg JR, Norman PJ, Hollenbach JA. Front Immunol 12 674778 (2021)
  45. Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction. Grifoni A, Montesano C, Patronov A, Colizzi V, Amicosante M. Biomed Res Int 2013 283805 (2013)
  46. Biology of plasmacytoid dendritic cells and natural killer cells in HIV-1 infection. Lakshmanan V, Alter G, Altfeld M, Bhardwaj N. Curr Opin HIV AIDS 2 189-200 (2007)
  47. Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection. Adland E, Hill M, Lavandier N, Csala A, Edwards A, Chen F, Radkowski M, Kowalska JD, Paraskevis D, Hatzakis A, Valenzuela-Ponce H, Pfafferott K, Williams I, Pellegrino P, Borrow P, Mori M, Rockstroh J, Prado JG, Mothe B, Dalmau J, Martinez-Picado J, Tudor-Williams G, Frater J, Stryhn A, Buus S, Teran GR, Mallal S, John M, Buchbinder S, Kirk G, Martin J, Michael N, Fellay J, Deeks S, Walker B, Avila-Rios S, Cole D, Brander C, Carrington M, Goulder P. J. Virol. 92 (2018)
  48. Prediction of peptide binding to a major histocompatibility complex class I molecule based on docking simulation. Ishikawa T. J. Comput. Aided Mol. Des. 30 875-887 (2016)
  49. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705. Jones MA, Hislop AD, Snaith JS. Org. Biomol. Chem. 4 3769-3777 (2006)
  50. Salmonella Exhibit Altered Cellular Localization in the Presence of HLA-B27 and Codistribute with Endo-Reticular Membrane. Kriston-Vizi J, Lenart I, Iwawaki T, Gould K, Nesbeth D, Powis SJ, Antoniou AN. J Immunol Res 2022 9493019 (2022)
  51. Epitope length variants balance protective immune responses and viral escape in HIV-1 infection. Pymm P, Tenzer S, Wee E, Weimershaus M, Burgevin A, Kollnberger S, Gerstoft J, Josephs TM, Ladell K, McLaren JE, Appay V, Price DA, Fugger L, Bell JI, Schild H, van Endert P, Harkiolaki M, Iversen AKN. Cell Rep 38 110449 (2022)
  52. HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2+ NK cells in Lassa virus infection. Wauquier N, Petitdemange C, Tarantino N, Maucourant C, Coomber M, Lungay V, Bangura J, Debré P, Vieillard V. EBioMedicine 40 605-613 (2019)
  53. Human herpesvirus diversity is altered in HLA class I binding peptides. Palmer WH, Telford M, Navarro A, Santpere G, Norman PJ. Proc Natl Acad Sci U S A 119 e2123248119 (2022)
  54. Multi-modal Binding of a 'Self' Peptide by HLA-B*27:04 and B*27:05 Allelic Variants, but not B*27:09 or B*27:06 Variants: Fresh Support for Some Theories Explaining Differential Disease Association. Rana MK, Luthra-Guptasarma M. Protein J. 35 346-353 (2016)


Quick links